American ginseng significantly reduced the progression of high-fatdiet-enhanced colon carcinogenesis in apcmin/+ mice

Journal of Ginseng Research

Volumn 39, Issue 3, 2015, Pages 230-237

  Yu, Chunhao ^a,b,c   Wen, Xiao Dong ^b,c   Zhang, Zhiyu ^b,c   Zhang, Chun Feng ^b,c   Wu, Xiaohui ^b,c   He, Xin ^b,c   Liao, Yang ^b,d   Wu, Ningning ^b,e   Wang, Chong Zhi ^b,c   Du, Wei ^b,d   He, Tong Chuan ^b,e   Yuan, Chun Su ^b,c  

^a HUAIYIN INSTITUTE OF TECHNOLOGY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

ApcMin mice; Colorectal cancer; Ginsenoside metabolites; Inflammatory cytokines; Panax quinquefolius L

Indexed keywords

GINSENG EXTRACT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; COLON; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; INTESTINE FLORA; LIPID DIET; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PANAX QUINQUEFOLIUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE; WEIGHT CHANGE;

MUS; PANAX GINSENG; PANAX QUINQUEFOLIUS;

EID: 84936847424     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2014.12.004     Document Type: Article

References (52)

1. National Cancer Institute. Colon and rectal cancer. [Internet]. Bethesda (MD): NCI; 2014. [cited 2014 Jun 2] Available from:, http://www.cancer.gov/ cancertopics/types/colon-and-rectal.
2. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64: 104-17.
3. National Cancer Institute. SEER stat fact sheets: colon and rectum. [Internet]. Bethesda (MD): NCI; 2014. [cited 2014 Jun 2] Available from:, http://seer. cancer.gov/statfacts/html/colorect.html#risk.
4. Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 1995;4:401-8.
5. Yun TK. Panax ginsengda non-organ-specific cancer preventive? Lancet Oncol 2001;2:49-55.
6. Gu C, Qiao J, Zhu M, Du J, Shang W, Yin W, Wang W, Han M, Lu W. Preliminary evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells. Am J Chin Med 2013;41:443-58.
7. Park EY, Kim MH, Kim EH, Lee EK, Park IS, Yang DC, Jun HS. Efficacy comparison of Korean ginseng and American ginseng on body temperature and metabolic parameters. Am J Chin Med 2014;42:173-87.
8. McCarthy N. Tumorigenesis: all together now. Nat Rev Cancer 2013;13: 148-9.
9. Lewis B, Lin J, Wu X, Xie H, Shen B, Lai K, Manilich E, Liu X. Crohn’s disease-like reaction predicts favorable prognosis in colitis-associated colorectal cancer. Inflamm Bowel Dis 2013;19:2190-8.
10. Foersch S, Waldner MJ, Neurath MF. Colitis and colorectal cancer. Dig Dis 2012;30:469-76.
11. Xiaoguang C, Hongyan L, Xiaohong L, Zhaodi F, Yan L, Lihua T, Rui H. Cancer chemopreventive and therapeutic activities of red ginseng. J Ethnopharmacol 1998;60:71-8.
12. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 2001;16:S28-37.
13. Qi LW, Wang CZ, Yuan CS. American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol 2010;80:947-54.
14. Poudyal D, Le PM, Davis T, Hofseth AB, Chumanevich A, Chumanevich AA, Wargovich MJ, Nagarkatti M, Nagarkatti PS, Windust A, et al. A hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: anti-inflammatory and proapoptotic mechanisms. Cancer Prev Res (Phila) 2012;5:685-96.
15. Hofseth LJ, Wargovich MJ. Inflammation, cancer, and targets of ginseng. J Nutr 2007;137:S183-5.
16. Zhu J, Jiang Y, Wu L, Lu T, Xu G, Liu X. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience 2012;202:342-51.
17. Jin Y, Hofseth AB, Cui X, Windust AJ, Poudyal D, Chumanevich AA, Matesic LE, Singh NP, Nagarkatti M, Nagarkatti PS, et al. American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells. Cancer Prev Res (Phila) 2010;3:339-47.
18. min/þ mice by SHetA2 (NSC721689) without toxicity. Cancer Prev Res (Phila) 2013;6:908-16.
19. Derry MM, Raina K, Balaiya V, Jain AK, Shrotriya S, Huber KM, Serkova NJ, Agarwal R, Agarwal C. Grape seed extract efficacy against azoxymethaneinduced colon tumorigenesis in A/J mice: interlinking miRNA with cytokine signaling and inflammation. Cancer Prev Res (Phila) 2013;6:625-33.
20. Khan R, Khan AQ, Lateef A, Rehman MU, Tahir M, Ali F, Hamiza OO, Sultana S. Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats. PLoS One 2013;8:56020.
21. Qi LW, Wang CZ, Yuan CS. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry 2011;72:689-99.
22. Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J. Brief communication: American ginseng reduces warfarin’s effect in healthy patients: a randomized, controlled trial. Ann Intern Med 2004;141:23-7.
23. Christensen LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 2009;55:1-99.
24. Qi LW, Wang CZ, Yuan CS. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep 2011;28:467-95.
25. Baek SH, Bae ON, Park JH. Recent methodology in ginseng analysis. J Ginseng Res 2012;36:119-34.
26. Wang CZ, Du GJ, Zhang Z, Wen XD, Calway T, Zhen Z, Musch MW, Bissonnette M, Chang EB, Yuan CS. Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer. Int J Oncol 2012;40:1970-6.
27. Jin HR, Zhao J, Zhang Z, Liao Y, Wang CZ, Huang WH, Li SP, He TC, Yuan CS, Du W. The antitumor natural compound falcarindiol promotes cancer cell death by inducing endoplasmic reticulum stress. Cell Death Dis 2012;3:e376.
28. Fichera A, Guo Y, Romero L, Michelassi F, Arenas RB. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism. J Surg Res 1997;69:188-92.
29. e/e mice, a model of inflammatory bowel diseases. Nutrition 2012;28:324-30.
30. Min/þ mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention. Cancer Prev Res (Phila) 2011;4:2015-26.
31. Sun S, Qi LW, Du GJ, Mehendale SR, Wang CZ, Yuan CS. Red notoginseng: higher ginsenoside content and stronger anticancer potential than Asian and American ginseng. Food Chem 2011;125:1299-305.
32. Qi LW, Wang HY, Zhang H, Wang CZ, Li P, Yuan CS. Diagnostic ion filtering to characterize ginseng saponins by rapid liquid chromatography with time-offlight mass spectrometry. J Chromatogr A 2012;1230:93-9.
33. Wan JY, Liu P, Wang HY, Qi LW, Wang CZ, Li P, Yuan CS. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. J Chromatogr A 2013;1286:83-92.
34. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC, Yuan CS. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 2007;73:669-74.
35. Wang CZ, Ni M, Sun S, Li XL, He H, Mehendale SR, Yuan CS. Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA. J Agric Food Chem 2009;57:2363-7.
36. Dougherty U, Mustafi R, Wang Y, Musch MW, Wang CZ, Konda VJ, Kulkarni A, Hart J, Dawson G, Kim KE, et al. American ginseng suppresses Western dietpromoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR. BMC Complement Altern Med 2011;11:111-21.
37. Madka V, Rao CV. Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Curr Cancer Drug Targets 2013;13:542-57.
38. Garcia Rodriguez LA, Cea-Soriano L, Tacconelli S, Patrignani P. Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials. Recent Results Cancer Res 2013;191:67-93.
39. Zhou Y, Boudreau DM, Freedman AN. Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf 2014;23:43-50.
40. Chen S, Qu X, Wan P, Li QW, Wang Z, Guo F, Bai L, Hu Z, Tan W, Li J. Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells. Am J Chin Med 2013;41:665-82.
41. Liu S, Wang XJ, Liu Y, Cui YF. PI3K/AKT/mTOR signaling is involved in (e)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Am J Chin Med 2013;41:629-42.
42. Wang CY, Bai XY, Wang CH. Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. Am J Chin Med 2014;42:543-59.
43. Park EH, Kim YJ, Yamabe N, Park SH, Kim HK, Jang HJ, Kim JH, Cheon GJ, Ham J, Kang KS. Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell. J Ginseng Res 2014;38:22-7.
44. De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E, Fazio VM. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog 2011;10:9.
45. Wen XD, Wang CZ, Yu C, Zhang Z, Calway T, Wang Y, Li P, Yuan CS. Salvia miltiorrhiza (dan shen) significantly ameliorates colon inflammation in dextran sulfate sodium induced colitis. Am J Chin Med 2013;41:1097-108.
46. Day SD, Enos RT, McClellan JL, Steiner JL, Velázquez KT, Murphy EA. Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer. Cytokine 2013;64:454-62.
47. Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 2000;60:5040-4.
48. Yuan CS, Wang CZ, Wicks SM, Qi LW. Chemical and pharmacological studies of saponins with a focus on American ginseng. J Ginseng Res 2010;34:160-7.
49. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003;31:1065-71.
50. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004;95:153-7.
51. Oh GS, Pae HO, Choi BM, Seo EA, Kim DH, Shin MK, Kim JD, Kim JB, Chung HT. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett 2004;205:23-9.
52. Punja ZK. American ginseng: research developments, opportunities, and challenges. J Ginseng Res 2011;35:368-74.